Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKesson
Medtronic
Express Scripts
Boehringer Ingelheim
Moodys
Mallinckrodt

Last Updated: December 15, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for AZD6738

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the drug development status for AZD6738?

AZD6738 is an investigational drug.

There have been 21 clinical trials for AZD6738. The most recent clinical trial was a Phase 1 trial, which was initiated on March 9th 2018.

The most common disease conditions in clinical trials are Carcinoma, Leukemia, and Neoplasms. The leading clinical trial sponsors are AstraZeneca, Samsung Medical Center, and National Cancer Institute (NCI).

There are five US patents protecting this investigational drug and forty international patents.

Recent Clinical Trials for AZD6738
TitleSponsorPhase
Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast CancerNational Cancer Institute (NCI)Phase 2
Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast CancerM.D. Anderson Cancer CenterPhase 2
AZD6738 & Gemcitabine as Combination TherapyAstraZenecaPhase 1

See all AZD6738 clinical trials

Clinical Trial Summary for AZD6738

Top disease conditions for AZD6738
Top clinical trial sponsors for AZD6738

See all AZD6738 clinical trials

US Patents for AZD6738

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
AZD6738   Start Trial Chemical compounds Astrazeneca AB (Sodertalje, SE)   Start Trial
AZD6738   Start Trial Chemical compounds AstraZeneca AB (Sodertalje, SE)   Start Trial
AZD6738   Start Trial Chemical compounds AstraZeneca AB (Sodertalje, SE)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Baxter
Boehringer Ingelheim
Merck
Mallinckrodt
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.